Ganga Pharmaceuticals Ltd | Scrip Code : 539680 | Quarter ending :September 2016 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 9 | 27,09,550 | 27,09,550 | 66.71 | 27,09,550 | 66.71 | 27,09,550 | 100.00 | 21,70,050 | - | - | - | (B) Public | 361 | 13,51,950 | 13,51,950 | 33.29 | 13,51,950 | 33.29 | 2,71,950 | 20.12 | 11,60,000 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 370 | 40,61,500 | 40,61,500 | 100.00 | 40,61,500 | 100.00 | 29,81,500 | 73.41 | 33,30,050 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|